MedTrace Logo

Effects of a 10-Week Zumba Program on Anxiety and Depression in Adults

NCT07317908 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-01-09

No results posted yet for this study

Summary

This randomized controlled trial aimed to examine the effects of a 10-week Zumba exercise program on anxiety and depression levels in healthy adults. Participants aged 40 to 65 years were randomly assigned to either a Zumba intervention group or a control group that maintained their usual lifestyle. The intervention consisted of three supervised Zumba sessions per week, each lasting approximately 50 minutes. Anxiety and depression were assessed before and after the intervention using the Hospital Anxiety and Depression Scale (HADS). The study sought to determine whether a structured, group-based aerobic exercise program could improve psychological well-being in a non-clinical adult population.

Conditions

Interventions

BEHAVIORAL

Zumba-based Exercise Program

Participants assigned to this intervention received a supervised Zumba-based exercise program lasting 10 consecutive weeks. The intervention consisted of group-based aerobic dance sessions conducted several times per week and led by a qualified instructor. Sessions included choreographed dance movements performed to music, designed to elicit moderate-to-vigorous physical activity and to promote cardiovascular fitness and overall physical engagement. The program followed a standardized structure across sessions and was implemented as the sole intervention during the study period.

Sponsors & Collaborators

  • Manuel Jesús Rodríguez Chavarría

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-03
Primary Completion
2025-04-16
Completion
2025-04-16

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07317908 on ClinicalTrials.gov